In Depth

Featured article

What’s in a name: Agencies struggle to keep up with new drug names

Also in this section

How gene therapies can transform sickle cell disease treatment

Childproof packaging: How things are changing for consumer drugs

BIO-Europe 2023: Pharma balances on shaky financial and legislative footing

Reform in South Korea means progression in improving time to reimbursement

UK pharma manufacturing prepares for imminent shake up in 2024

02/23/2024 23:34:17
  • Home | What's in a name
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Lactalis Ingredients
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • BEA Technologies
  • Natoli
  • In Depth
  • What’s in a name: Agencies struggle to keep up with new drug names
  • How gene therapies can transform sickle cell disease treatment
  • Childproof packaging: How things are changing for consumer drugs
  • BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
  • Reform in South Korea means progression in improving time to reimbursement
  • Q&A: UK pharma manufacturing prepares for imminent shake up in 2024
  • Bio Image Systems
  • Pfanstiehl
  • Listings
  • Events
  • Awards
  • Buyer's Guides
  • Next issue
11/28/2023 00:00:00